Research & Development
The analytical research & development section supports all the developmental work of formulation development. It is well equipped with highly sophisticated instruments and undertakes method development, stability studies, validation and method transfer.
Our research & development team have solved a number of complex challenges across oral solid, liquid, semi-solid dosage forms as well as parenterals – whether it is drug product complexity or drug substance complexity. We have the capability to deliver quality products within established timelines, at low costs without compromising on quality.
Although our drug products are developed adhering to Indian regulatory requirements and ICH guidelines; we consider the International regulatory agencies like USFDA in controlling the levels of inactive ingredients to be under IIG limits, following dissolution methods as per dissolution methods database for drug products. The drug substances are procured after detailed understanding of solubility and polymorphs to use in our formulations.
Cutting-Edge R&D Capabilities
Marketing efforts of Santheras Pharmaceuticals are supported by a strong R&D team comprising highly qualified formulation and analytical scientists. It is fully equipped with state-of-the-art equipment, facilitating development of conventional and novel drug products complying to high standards of quality.
We are pioneering sophisticated drug delivery mechanisms that improve therapeutic efficacy and patient compliance. These include extended-release formulations, controlled-release technologies, and more.
Our R&D team specializes in creating innovative topical formulations, such as emulgels, designed to localize drug action effectively at the target site while minimizing systemic exposure.
Leveraging advanced technologies, we aim to enhance the precision of drug delivery to ensure maximum therapeutic benefits with minimal side effects. Our relentless focus on innovation has also positioned us as pioneers in dosage forms such as dispersible tablets and mouth-dissolving tablets, offering convenience and enhanced compliance for patients with swallowing difficulties.
Advanced Pharmaceutical Product Development
Our capabilities of drug product development are:
Immediate Release Tablets, Effervescent Tablets, Orally Disintegrating Tablets, Chewable Tablets, Bilayered Tablets, Inlay Tablets, Delayed Release Tablets, and Extended Release Tablets.
Powder for Suspension / Syrups and Oral Liquid Suspension / Syrups developed with advanced formulation technologies to support stability, patient compliance, and dosage accuracy.
Hard Gelatin Capsules and Multiple Unit Delayed Release / Extended Release Pellets (MUPS) designed to improve therapeutic effectiveness and controlled drug delivery.
Powder for Injection and Liquid Injection formulations manufactured with strict quality standards and advanced pharmaceutical processing systems.
Advanced topical dosage forms including Creams, Gels, and Ointments developed for improved localized therapeutic action and patient comfort.
Building Trust Through Quality Healthcare Solutions
Expertise in developing and manufacturing reliable pharmaceutical formulations.
